[HTML][HTML] Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double …

Y Zheng, J Ching, CW Cheng, WC Lam, KL Chan… - Chinese Medicine, 2021 - Springer
Background Irritable bowel syndrome (IBS) is a common gastrointestinal functional disease.
Adults with IBS may experience abdominal pain, change of bowel habits, and abnormal …

[HTML][HTML] Common traditional Chinese medicine therapies for diarrhea-predominant irritable bowel syndrome: An overview of systematic reviews

J Zhao, X Li, X Chen, H Zheng, K Ye, Y Shi… - Journal of Traditional …, 2022 - Elsevier
Objective To critically evaluate and summarize the methodological quality of systematic
reviews (SRs) and present objective and important outcomes on the effectiveness of …

[HTML][HTML] The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded …

X Guo, M Xuan, H Zheng, S Qin, H Wu, S Huang… - Trials, 2021 - Springer
Background Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common chronic
digestive disease. Recent observational studies have reported that the Chinese herbal …

Efficacy of Chinese herbal medicine for diarrhea‐predominant irritable bowel syndrome: a meta‐analysis of randomized, double‐blind, placebo‐controlled trials

JJ Zhu, S Liu, XL Su, ZS Wang, Y Guo… - Evidence‐Based …, 2016 - Wiley Online Library
Objective. To explore the efficacy of Chinese herbal medicine in treating diarrhea‐
predominant irritable bowel syndrome (D‐IBS). Methods. Four English and four Chinese …

[HTML][HTML] External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis

X Wei, Y Wen, Y Wei, X Liang, X Ma, B Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Irritable bowel syndrome with diarrhea (IBS-D) is a chronic functional
gastrointestinal disorder that has a significant impact on quality of life, work productivity, and …

[HTML][HTML] Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo …

SB Liang, M Han, HJ Cheng, QY Zhang, NW Zhang… - Trials, 2022 - Springer
Introduction Diarrhea-predominant irritable bowel syndrome (IBS-D) is a bowel disease with
a high incidence. It significantly reduces the quality of life of patients and affects the patient's …

Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled …

N Liu, J Li, Y Wang, S Zhang - Journal of Ethnopharmacology, 2023 - Elsevier
Abstract Ethnopharmacological relevance: Shuganijanpi Therapy (SGJP), Jianpi Therapy
(JP), Sugan Therapy (SG), Jianpiwenshen Therapy (JPWS), and Shuganijanpiwenshen …

[HTML][HTML] Traditional Chinese medicine for irritable bowel syndrome: A protocol for meta-analysis

CJ Yao, YL Li, MJ Pu, LH Luo, PM Feng - Medicine, 2020 - journals.lww.com
Background: Irritable bowel syndrom (IBS) is a common functional gastrointestinal disorder
which is characterized as recurrent abdominal pain, abdominal discomfort, and abnormal …

[HTML][HTML] Comparative effectiveness of pharmacological treatments for patients with diarrhea-predominant irritable bowel syndrome: Protocol of a systematic review and …

L Yue, M Chen, TC Tang, TW She, YY Chen, H Zheng - Medicine, 2018 - journals.lww.com
Background: Several pharmacological treatments are recommended by guidelines with
moderate to high evidence for the treatment of diarrhea-predominant irritable bowel …

[HTML][HTML] Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial

L Ji, X Zhao, Y Zhang, P Zhao, R Gong, F Li, H Huang - Medicine, 2022 - journals.lww.com
Background: Diarrhea-predominant irritable bowel syndrome (D-IBS) is the main subtypes of
irritable bowel syndrome (IBS). In recent years, more than half of IBS patients have received …